Literature DB >> 7173299

Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.

H T Folgering, J F Borm, R H van Haaren.   

Abstract

Maximal exercise performance by eight healthy male subjects was tested after one week of medication with slow-release metoprolol 200 mg/d (metoprolol-SR), atenolol 200 mg/d or placebo, in a double blind crossover trial. The maximal working capacity was significantly decreased after atenolol and metoprolol-SR. Plasma glucose and FFA concentrations during the exercise test did not change: either after placebo therapy or after beta-blockade. The anerobic threshold did not change after beta-blockade, but the changes in lactate due to the exercise were less after beta-blockade. Neither beta-blocker affected the exercise-induced alteration in airway resistance. Both drugs caused a small but significant ventilatory depression at rest and at 75% of maximal exercise. It is concluded that the limiting factor in maximal exercise performance after beta 1-adrenergic blockade does not lie in oxygen transport to the working muscles via ventilation and the circulation, but is most probably due to anaerobic metabolism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7173299     DOI: 10.1007/bf00613607

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  [Reduction of exercise inudced hyperventilation by blocking beta adrenergic receptors].

Authors:  A Scheen; J Juchmes; A Cession-Fossion
Journal:  C R Seances Soc Biol Fil       Date:  1976

2.  DETERMINATION OF FREE FATTY ACIDS IN PLASMA BY A COLORIMETRIC PROCEDURE: AN APPRAISAL OF THE METHOD AND COMPARISON WITH OTHER TECHNICS.

Authors:  H B ANSTALL; J M TRUJILLO
Journal:  Clin Chem       Date:  1965-08       Impact factor: 8.327

3.  Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.

Authors:  B G Hansson; J F Dymling; H Hedeland; U L Hulthén
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

4.  Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.

Authors:  H Folgering; M van Bussel
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

5.  Effect of exercise on renal clearance of atenolol.

Authors:  W D Mason; G Kochak; N Winer; I Cohen
Journal:  J Pharm Sci       Date:  1980-03       Impact factor: 3.534

6.  Controlled study of atenolol in treatment of hypertension.

Authors:  L Hansson; H Aberg; B E Karlberg; A Westerlund
Journal:  Br Med J       Date:  1975-05-17

7.  Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.

Authors:  H C Brown; S G Carruthers; G D Johnston; J G Kelly; J McAinsh; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

8.  Hemodynamic response to graded exercise after chronic beta-adrenergic blockade.

Authors:  T Reybrouck; A Amery; L Billiet
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-02

9.  The effects of oral propranolol and metoprolol on lung function and exercise performance in chronic airways obstruction.

Authors:  C R McGavin; I P Williams
Journal:  Br J Dis Chest       Date:  1978-10

10.  Acute haemodynamic effects of metoprolol in hypertensive patients.

Authors:  R Sannerstedt; H Wasir
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.